Clinical trials: Symptomatic Hypogonadism
Hypogonadism
Nebido Versus Placebo in Elderly Men With Typical Symptoms of Late Onset Hypogonadism Over a Period of 54 Weeks
To evaluate the safety and efficacy of Nebido compared to placebo in elderly men aged 50 and over with symptomatic late onset hypogonadism
- Trial name
- NCT00710827
- Testing
- NEBIDO
- Where
- 25 sites in Germany, Italy and 4 more
- Sponsor
- Bayer
Hypogonadism
NEBIDO in Symptomatic Late Onset Hypogonadism (SLOH)
The design of the study is a standard double-blind design, which is needed in this study to allow for unbiased evaluation of efficacy and safety.
- Trial name
- NCT01092858
- Testing
- Testosterone Undeconate (Nebido, BAY86-5037)
- Where
- Germany
- Volunteers
- 4 people
- Sponsor
- Bayer
Hypogonadism, Androgens
Effects of Andriol Testocaps in Symptomatic Late-Onset Hypogonadism (43203)
In this study we have evaluated the effects of three different doses of oral testosterone undecanoate in aging men presenting with a combination of symptoms suggestive of hypogonadism and low blood levels of the male hormone…
- Trial name
- NCT00434824
- Testing
- Oral testosterone undecanoate (Andriol)
- Volunteers
- 322 people
- Sponsor
- Merck Sharp & Dohme LLC